Page last updated: 2024-08-24

tenofovir and Growth Disorders

tenofovir has been researched along with Growth Disorders in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	1 (50.00)	2.80

Authors

Authors	Studies
Acosta, S; Balogun, K; Guzman Lenis, MS; Mount, HT; Sarkar, A; Serghides, L	1
Bunders, MJ; Cohen, S; Denneman, L; Godfried, MH; Kuijpers, TW; Nellen, JF; Pajkrt, D; Scherpbier, HJ; Smit, C; van de Plas, A; van Leeuwen, E; Weijsenfeld, AM	1

Other Studies

2 other study(ies) available for tenofovir and Growth Disorders

Article	Year
In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice. PloS one, 2020, Volume: 15, Issue:11 Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir	2020
In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants. AIDS (London, England), 2016, 08-24, Volume: 30, Issue:13 Topics: Anti-HIV Agents; Birth Weight; Child Development; Female; Fetal Development; Fetal Growth Retardation; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Tenofovir	2016

Article

Year

In utero exposure to protease inhibitor-based antiretroviral regimens delays growth and developmental milestones in mice.

PloS one, 2020, Volume: 15, Issue:11

Topics: Animals; Anti-HIV Agents; Atazanavir Sulfate; Developmental Disabilities; Dideoxynucleosides; Emtricitabine; Exploratory Behavior; Female; Fetal Growth Retardation; Growth Disorders; Hand Strength; HIV Protease Inhibitors; Homing Behavior; Lamivudine; Male; Mice; Mice, Inbred C57BL; Pregnancy; Prenatal Exposure Delayed Effects; Random Allocation; Reflex, Abnormal; Reflex, Righting; Sensation Disorders; Taxis Response; Tenofovir

2020

In-utero exposure to tenofovir is associated with impaired fetal and infant growth: need for follow-up studies in combination antiretroviral therapy/HIV-exposed infants.

AIDS (London, England), 2016, 08-24, Volume: 30, Issue:13

Topics: Anti-HIV Agents; Birth Weight; Child Development; Female; Fetal Development; Fetal Growth Retardation; Follow-Up Studies; Growth Disorders; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Prenatal Exposure Delayed Effects; Retrospective Studies; Tenofovir

2016